Aims Primary prevention of sudden cardiac death (SCD) in non-ischemic heart failure (HF)
patients remains a topic of debate at cardiac resynchronization therapy (CRT) implantation …

Device therapy for heart failure has rapidly evolved over 2 decades. The knowledge of
indications, assessment lead and device technology has expanded to include CRT, leadless …

Mit der Neufassung der ESC-Leitlinie zu Kammerarrhythmien und dem plötzlichen Herztod
ist nach 7 Jahren eine praxisnahe Aktualisierung entstanden. Die vorliegende Arbeit …

Choosing the optimal device during cardiac resynchronization therapy (CRT) upgrade can
be challenging. Therefore, we sought to provide a solution for identifying patients in whom …

Background Some patients with cardiac resynchronisation therapy (CRT) experience super-
response (LVEF improvements to≥ 50%). At generator exchange (GE), downgrading (DG) …

Introduction Over the course of 2022, numerous key clinical trials with valuable contributions
to clinical cardiology were published or presented at major international conferences. This …

Introduction Older patients may be less likely to receive cardiac resynchronisation therapy
(CRT) for the management of heart failure. We aimed to describe the differences in clinical …

Aims Late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance
(CMR) can evaluate myocardial scar associated with a higher risk of sudden cardiac death …

In this issue of the European Heart Journal, cardiac resynchronization therapy (CRT) with
pacing only (CRT-P) was reported to be noninferior to CRT with an implantable cardioverter …

Current guidelines lack clear recommendations between the implantation of cardiac
resynchronization therapy (CRT) with defibrillator (CRT-D) and CRT with pacemaker (CRT …